Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air



Status:Recruiting
Conditions:Cancer, Cancer, Pancreatic Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:October 2013
Contact:Kevin Barga
Email:kbarga@hackensackumc.org
Phone:(551)996-8017

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the
Spectrosense EVA system, which is combination of a gas chromatography (GC) and software
algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the
best discrimination between Pancreatic Cancer sick population and healthy population. The
gold standard for identifying sick/healthy population is biopsy proven Pancreatic cancer.


Pancreatic cancer Group

Inclusion Criteria:

- Age from 18 years old

- Pancreatic cancer positive biopsy

- Before any treatment

- Signed Informed Patient Consent

Exclusion Criteria:

- Age under 18 years old

- Neoadjovant treatment

- Post surgery for Pancreatic cancer

- A history of any other cancer type, except skin cancer that is not melanoma

Healthy Group

Inclusion Criteria:

- Healthy patients

- No history of Pancreatic cancer

- Signed Informed Patient Consent

Exclusion Criteria:

- History of Pancreatic cancer

- Pancreatic cancer background in the family

- A history of any other cancer type, except skin cancer that is not melanoma
We found this trial at
1
site
Hackensack University Medical Center
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials